Compare GRFS & GLBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | GLBE |
|---|---|---|
| Founded | 1940 | 2013 |
| Country | Spain | Israel |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.7B |
| IPO Year | N/A | 2020 |
| Metric | GRFS | GLBE |
|---|---|---|
| Price | $7.99 | $29.83 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 12 |
| Target Price | $10.15 | ★ $47.08 |
| AVG Volume (30 Days) | 589.6K | ★ 1.7M |
| Earning Date | 07-28-2022 | 05-13-2026 |
| Dividend Yield | ★ 1.80% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.49 | $31.78 |
| Revenue Next Year | $6.42 | $24.45 |
| P/E Ratio | ★ $18.67 | $89.26 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.39 | $26.85 |
| 52 Week High | $11.14 | $41.94 |
| Indicator | GRFS | GLBE |
|---|---|---|
| Relative Strength Index (RSI) | 48.45 | 47.24 |
| Support Level | $7.87 | $29.92 |
| Resistance Level | $9.78 | $36.74 |
| Average True Range (ATR) | 0.21 | 1.57 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 50.26 | 50.86 |
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
Global E Online Ltd provides e-commerce solutions. The company offers a platform to enable and accelerate direct-to-consumer cross-border e-commerce. The platform was purpose-built for international shoppers to buy seamlessly online and for merchants to sell from, and to, anywhere in the world. The company localizes the shopper experience to make international transactions as seamless as domestic ones. The platform increases the conversion of international traffic into sales by removing much of the complexity associated with international e-commerce. The company derives maximum revenue from the United States.